Sotagliflozin

Overview

Sotagliflozin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3039507).

API suppliers (2)

Suppliers of Sotagliflozin backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• LEE PHARMA LTDIndia1 active DMF
• Pharmaron Beijing Co., Ltd.China1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Sotagliflozin expires 7 Oct 2030 and exclusivity 26 May 2028. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyloxane-3,4,5-triol

Canonical SMILES

CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)SC)O)O)O)Cl

InChIKey

QKDRXGFQVGOQKS-CRSSMBPESA-N